🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Randomized study of PRT054021 40 mg and 15 mg bid vs. enoxaparin 30 mg q12h...
Status
Completed
Location
Montreal General Hospital
Start Date
2006-05
Trial ID
NCT00375609
Treatments Being Tested
This trial was a Phase 1, open-label, multicenter study of the pharmacokine...
Status
Terminated
Location
Children's Hospital Los Angeles
Start Date
2018-07-13
Trial ID
NCT03346083
Treatments Being Tested
Prevention of stroke in patients with atrial fibrillation (AF). Hypothesis:...
Status
Completed
Location
Portola Investigational Site
Start Date
2008-10
Trial ID
NCT00742859
Treatments Being Tested
This is a open label, single center, single oral dose, study of PRT054021, ...
Status
Completed
Location
Multiple Locations
Start Date
2007-09
Trial ID
NCT01765868
Treatments Being Tested
This is a single center open label randomized 4-period 2-sequence replicate...
Status
Completed
Location
Multiple Locations
Start Date
2015-09
Trial ID
NCT02596100
Treatments Being Tested
This is a randomized, double-blind, single center study in healthy voluntee...
Status
Terminated
Location
WCCT Global
Start Date
2015-08-06
Trial ID
NCT03330457
Treatments Being Tested
This is a open label, single center, single oral dose, study of PRT054021, ...
Status
Completed
Location
Multiple Locations
Start Date
2007-09
Trial ID
NCT01765855
Treatments Being Tested
The purpose of this study is to evaluate whether extended prophylaxis with ...
Status
Completed
Location
Multiple Locations
Start Date
2012-03
Trial ID
NCT01583218
Treatments Being Tested
Single center, prospective open label PK and PD study of betrixaban in subj...
Status
Completed
Location
Clinical Pharmacology of Miami
Start Date
2017-11-16
Trial ID
NCT03397888
Treatments Being Tested
Part 1 - Evaluate the real-world implementation of extended prophylaxis wit...
Status
Withdrawn
Location
Durham
Start Date
2018-09
Trial ID
NCT03613402